ZALCITABINE Side Effects

6011715-6 | Cytomegalovirus Myocarditis, Kaposi's Sarcoma
on Apr 23, 1992 Male patient from CANADA , weighting 160.9 lb, was treated with Zalcitabine (View Usage). Patient experienced the following unwanted or unexpected effects: cytomegalovirus myocarditis, kaposi's sarcoma (What is kaposi's sarcoma?). Zalcitabine dosage: . During the same period patient was treated with DIFLUCAN (View Diflucan Review and Diflucan Label ), COPHYLAC (View Cophylac Review and Cophylac Label ), DIGOXIN (View Digoxin Review and Digoxin Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), CYTOVENE (View Cytovene Review and Cytovene Label ), ENALAPRIL MALEATE (View Enalapril Maleate Review and Enalapril Maleate Label ), SLOW K (View Slow-k Review and Slow-k Label ), PENTAMIDINE (View Pentamidine Review and Pentamidine Label ).

6011711-9 | Aspartate Aminotransferase Increased, Coma, Factor Viii Deficiency, Haemorrhage, Liver Disorder
Patient was taking Zalcitabine (View Usage). Patient had the following side effects: aspartate aminotransferase increased, coma, factor viii deficiency, haemorrhage, liver disorder on Jan 07, 1994 from UNITED STATES Additional patient health information: Male patient , 40 years of age, was diagnosed with hiv infection (What is hiv infection?) and. Zalcitabine dosage: . During the same period patient was treated with ZIDOVUDINE (View Zidovudine Review and Zidovudine Label ), ENALAPRIL MALEATE (View Enalapril Maleate Review and Enalapril Maleate Label ), PENTAMIDINE (View Pentamidine Review and Pentamidine Label ).

6011700-4 | Progressive Multifocal Leukoencephalopathy
Adverse event was reported on Apr 24, 1996 by a Male patient taking Zalcitabine (View Usage) (Dosage: ) . Location: SPAIN , weighting 134.5 lb, After Zalcitabine was administered, patient had the following side effects: progressive multifocal leukoencephalopathy. During the same period patient was treated with ZIDOVUDINE (View Zidovudine Review and Zidovudine Label ).

6011400-0 | Bronchitis, Herpes Zoster, Kaposi's Sarcoma, Oesophageal Candidiasis, Oral Candidiasis, Thrombocytopenia, Weight Decreased
on Jun 26, 1995 Male patient from GERMANY , 53 years of age, was diagnosed with hiv infection (What is hiv infection?), herpes zoster, bronchitis (What is bronchitis?) and was treated with Zalcitabine (View Usage). Patient experienced the following unwanted or unexpected effects: bronchitis (What is bronchitis?), herpes zoster, kaposi's sarcoma (What is kaposi's sarcoma?), oesophageal candidiasis, oral candidiasis, thrombocytopenia, weight decreased. Zalcitabine dosage: . During the same period patient was treated with FLUCONAZOLE (View Fluconazole Review and Fluconazole Label ), IMMUNE GLOBULIN INTRAVENOUS (HUMAN) (View Immune Globulin Intravenous (human) Review and Immune Globulin Intravenous (human) Label ), ITRACONAZOL (View Itraconazol Review and Itraconazol Label ), PENTAMIDINE (View Pentamidine Review and Pentamidine Label ), ACYCLOVIR (View Acyclovir Review and Acyclovir Label ), ACC 600 (View Acc 600 Review and Acc 600 Label ).


5714722-3 | Kaposi's Sarcoma, Muscle Spasms
on Oct 21, 1994 Male patient from UNITED STATES , 45 years of age, was treated with Zalcitabine (View Usage). Patient had the following side effects: kaposi's sarcoma (What is kaposi's sarcoma?), muscle spasms. Zalcitabine dosage: .

5713212-1 | Aids Dementia Complex, Condition Aggravated, Disease Progression, Lethargy, Neuropathy Peripheral, Pneumonia
Patient was taking Zalcitabine (View Usage). After Zalcitabine was administered, patient had the following side effects: aids dementia complex, condition aggravated, disease progression, lethargy, neuropathy peripheral, pneumonia (What is pneumonia?) on Feb 05, 1996 from SWITZERLAND Additional patient health information: Male patient , weighting 169.3 lb, was diagnosed with hiv infection (What is hiv infection?) and. Zalcitabine dosage: . During the same period patient was treated with ZIDOVUDINE (View Zidovudine Review and Zidovudine Label ), DAPSONE (View Dapsone Review and Dapsone Label ), PYRIMETHAMIN (View Pyrimethamin Review and Pyrimethamin Label ). Patient was hospitalized.

5713204-2 | Diarrhoea, Mycobacterial Infection, Oesophageal Candidiasis, Weight Decreased
Adverse event was reported on Nov 30, 1995 by a Male patient taking Zalcitabine (View Usage) (Dosage: ) was diagnosed with hiv infection (What is hiv infection?), kaposi's sarcoma (What is kaposi's sarcoma?) and. Location: GERMANY , 42 years of age, weighting 143.3 lb, Patient experienced the following unwanted or unexpected effects: diarrhoea, mycobacterial infection, oesophageal candidiasis, weight decreased. During the same period patient was treated with AZT (View Azt Review and Azt Label ), PENTACARINAT (View Pentacarinat Review and Pentacarinat Label ), BLEOMYCIN/VINCRISTINE (View Bleomycin/vincristine Review and Bleomycin/vincristine Label ).

5713202-9 | Aids Encephalopathy, Grand Mal Convulsion, Hiv Wasting Syndrome, Leukopenia
on Jul 03, 1995 Male patient from GERMANY , 67 years of age, weighting 187.4 lb, was diagnosed with hiv infection (What is hiv infection?), candidiasis and was treated with Zalcitabine (View Usage). Patient had the following side effects: aids encephalopathy, grand mal convulsion, hiv wasting syndrome (What is hiv wasting syndrome?), leukopenia. Zalcitabine dosage: . During the same period patient was treated with DIFLUCAN (View Diflucan Review and Diflucan Label ), EUSAPRIM (View Eusaprim Review and Eusaprim Label ), CARBAMAZEPINE (View Carbamazepine Review and Carbamazepine Label ), PHENYTOIN (View Phenytoin Review and Phenytoin Label ).

5684997-8 | Abdominal Pain
on Jan 15, 1996 Male patient from AUSTRALIA , 47 years of age, weighting 114.6 lb, was diagnosed with hiv infection (What is hiv infection?), herpes simplex (What is herpes simplex?) and was treated with Zalcitabine (View Usage). After Zalcitabine was administered, patient had the following side effects: abdominal pain (What is abdominal pain?). Zalcitabine dosage: . During the same period patient was treated with BACTRIM (View Bactrim Review and Bactrim Label ), ACYCLOVIR (View Acyclovir Review and Acyclovir Label ), FLUCONAZOLE (View Fluconazole Review and Fluconazole Label ).

4657906-8 | Abortion Spontaneous
Patient was taking Zalcitabine (View Usage). Patient experienced the following unwanted or unexpected effects: abortion spontaneous on Aug 01, 2004 from Additional patient health information: Female patient , 23 years of age, . Zalcitabine dosage: . During the same period patient was treated with ZIDOVUDINE (View Zidovudine Review and Zidovudine Label ), ALCOHOL (View Alcohol Review and Alcohol Label ), COCAINE (View Cocaine Review and Cocaine Label ), MARIJUANA (View Marijuana Review and Marijuana Label ), PCP (View Pcp Review and Pcp Label ).